Zidovudine

Zidovudine, often known by the brand name AZT, is a medication used to treat HIV infection. It works by stopping the virus from copying itself. While it can help manage HIV, it can also cause side effects, like low blood counts, which is why it's usually used with other medications.

Brand names:Retrovir
Medication

What people taking Zidovudine report

Every report comes from a Lived member, sent anonymously.

Have you tried Zidovudine for HIV Infection?

NameHow it went

About Zidovudine

What It's For

Zidovudine, sold under the brand name Retrovir and often called AZT or ZDV, is a prescription medicine for HIV (human immunodeficiency virus). It was first approved in the United States in 1987. It is also one of the two ingredients in Combivir, a tablet that combines zidovudine with lamivudine, another HIV medicine. Zidovudine has two approved uses. The first is treating HIV infection in adults and children, always together with other HIV medicines rather than on its own. The second is lowering the chance that a pregnant person with HIV passes the virus to the baby. For that purpose it can be given during pregnancy, through a vein during labor and delivery, and by mouth to the newborn for the first six weeks of life.

How It Works

HIV is a retrovirus: to take over a cell, it has to copy its genetic material into DNA using an enzyme called reverse transcriptase. Zidovudine belongs to a group of HIV medicines called nucleoside reverse transcriptase inhibitors, or NRTIs. Inside the cell it is converted into a look-alike of one of the building blocks of DNA. When reverse transcriptase picks it up, the growing DNA chain cannot be extended, so the virus fails to finish its copy. Blocking this step lowers the amount of virus in the blood, which gives the immune system a chance to recover. For this reason it is always combined with other HIV medicines that attack the virus in different ways. It controls HIV but does not cure it.

Dosage & Administration

Zidovudine is usually taken by mouth, as capsules, tablets or a liquid. For adults treating HIV it is typically taken twice a day, alongside the rest of the HIV regimen. Children's doses are calculated from body weight, and the liquid is used when a child cannot reliably swallow a capsule. Newborns receive very small liquid doses measured with a fine-marked syringe, so caregivers should be shown exactly how to measure them. An intravenous form, given slowly through a vein, is used in the hospital when someone cannot take medicine by mouth and during labor and delivery. It is never injected into a muscle. People on dialysis or with very poor kidney function need a lower dose. If a dose is missed, take it as soon as you remember, but do not double the next dose. Keeping a supply on hand matters, because gaps in HIV treatment make the virus more likely to become resistant.

Side Effects

Headache, a general sense of feeling unwell, nausea, loss of appetite and vomiting are the most common side effects in adults, particularly early in treatment. Children more often have fever and cough. The most important serious effect is on the bone marrow, which makes blood cells. Zidovudine can cause anemia (too few red blood cells, which carry oxygen) and neutropenia (too few neutrophils, the white blood cells that fight bacterial infections). A drop in red cells can appear within two to four weeks, and low neutrophils usually after six to eight weeks. This is more likely in people with advanced HIV. Regular blood counts catch it early, and the dose may be paused, the medicine changed, or a transfusion given. Contact the care team right away about fever, chills or other signs of infection, unusual tiredness or weakness, pale skin, or unusual bleeding or bruising. Long-term use can cause muscle inflammation and weakness (myopathy), and gradual loss of fat from the face, arms, legs and buttocks (lipoatrophy). The fat loss may improve only partly, over months to years, after switching to another medicine. Rarely, zidovudine and related medicines cause lactic acidosis, a dangerous buildup of acid in the blood, along with an enlarged, fatty liver. This has been fatal in some cases and is reported more often in women and in people with obesity. Call the prescriber right away about unusual muscle pain, nausea or stomach pain, extreme tiredness, dizziness, feeling cold in the arms or legs, a fast or irregular heartbeat, yellowing of the skin or eyes, or dark urine; get emergency care if breathing becomes difficult. A new rash should also be reported promptly, because it can be the start of a serious allergic reaction.

Interactions & Warnings

Some medicines should not be combined with zidovudine. Ribavirin, a hepatitis C medicine, can worsen anemia, and in people with both HIV and hepatitis C, ribavirin or interferon alfa used with HIV treatment has led to serious liver failure; zidovudine is usually replaced in this situation. Stavudine, an older HIV medicine, and doxorubicin, a chemotherapy drug, work against zidovudine and should be avoided. Other medicines that suppress the bone marrow, such as ganciclovir (an antiviral for cytomegalovirus) and many cancer drugs, add to its effects on blood counts. Make sure every prescriber and pharmacist knows about all medicines and supplements you take. Zidovudine should not be used again by anyone who has had a severe allergic reaction to it, such as anaphylaxis or Stevens-Johnson syndrome, a serious blistering skin reaction. People who already have low blood counts, liver disease or kidney disease need closer monitoring or dose adjustment. Zidovudine is used in pregnancy, and data from a large pregnancy registry show no increase in birth defects overall compared with the general population. It lowers but does not remove the chance of passing HIV to the baby. The US label advises people taking zidovudine not to breastfeed, because HIV and the medicine can pass into breast milk; anyone planning to feed their baby should discuss options with their HIV care team.

What to Expect

Starting zidovudine means regular blood tests. These include blood counts to watch for anemia and low white cells, especially in the first few months, along with viral load (the amount of HIV in the blood) and CD4 count (a measure of immune cells) to show whether the overall regimen is working. Side effects such as nausea and headache often ease over the first weeks. HIV treatment is long term. Stopping or skipping doses lets the virus rebound and can make it resistant to treatment, so zidovudine should be continued even when you feel well and changed only with the prescriber. If blood counts fall, muscle problems develop or fat loss appears, the care team may switch to a different HIV medicine. Some people starting HIV treatment with a weak immune system have flare-ups of old, hidden infections as the immune system recovers; new signs of infection should be reported. For a newborn receiving zidovudine to prevent HIV, the medicine is usually given for six weeks, with blood tests to check the baby's blood counts.

Questions to Ask Your Doctor

  1. 1.Why is zidovudine part of my regimen, and are there other HIV medicines that might suit me better?
  2. 2.How often will my blood counts be checked, and what results would lead us to change treatment?
  3. 3.Which of my other medicines or supplements could interact with zidovudine?
  4. 4.What signs of muscle problems, fat loss or liver trouble should I watch for over the long term?
  5. 5.If I am pregnant or planning a pregnancy, how will zidovudine be used for me and my baby, and what are our feeding options?

Last reviewed • Oct 2026

Educational content, not medical advice.